Cellular content of cAMP generated by activation of adenylylcyclase (AC; EC 4.6.1.1) is a key determinant of functional responsiveness in the heart and other tissues. We have tested two hypotheses regarding the relationship between AC content and ␤-adrenergic receptor (␤AR)-mediated signal transduction in cardiac myocytes. First, that AC content limits adrenergic signal transduction, and, second, that increased AC, independent of (␤AR) number and G-protein content, yields a proportional increase in ␤AR-mediated transmembrane signaling. We used recombinant adenovirus to increase AC isoform VI (AC VI ) expression in neonatal cardiac myocytes. Cells that overexpressed AC VI responded to agonist stimulation with marked increases in cAMP production in proportion to protein expressed. In parallel experiments performed on cells transfected with lacZ (control) or AC VI , [ 3 H]forskolin binding, used to assess AC protein expression, was amplified 6-fold, while ␤AR-stimulated cAMP production from these cells was increased 7-fold. No changes in ␤AR number, or in the heterotrimeric GTP-binding proteins, G␣s or G␣i 2 , were observed. Previous studies indicate that increased cardiac expression of ␤AR or G␣s does not yield proportional increases in transmembrane adrenergic signaling. In contrast, the current data demonstrate that increased AC VI expression provides a proportional increase in ␤-adrenergic signal transduction. Our results show that the amount of AC sets a limit on transmembrane ␤-adrenergic signaling. We speculate that similar functional responses are possible in other cell types in which AC plays an important physiological role.
Cyclic adenosine 3Ј,5Ј-monophosphate (cAMP) is widely recognized as a second messenger that regulates intracellular metabolism, differentiated cell functions, and gene expression in mammalian cells. A large number of neurotransmitters and hormonal agonists act by means of membrane receptors and, in turn, heterotrimeric GTP-binding (G) proteins to regulate cAMP synthesis by adenylylcyclase (AC; EC 4.6.1.1). ␤-Adrenergic receptors (␤ARs) are among the most physiologically important type of receptors that promote cAMP formation. These receptors are of particular importance in the mammalian heart, where they regulate rate and force of cardiac contraction and relaxation.
The estimated molar proportions of the ␤AR⅐stimulatory GTP-binding protein (Gs)⅐AC complex suggest that ␤AR number or the amount of AC may set a limit on ␤AR-mediated transmembrane signaling. The molar proportions of these three elements in cardiac myocytes are 1:200:3 (␤AR:Gs:AC) as estimated by radioligand binding (␤AR), immunoblotting (Gs), and [ 3 H]forskolin binding (AC) (1, 2) . Previous efforts to increase transmembrane ␤-adrenergic signaling in the heart have examined the sequelae of ␤AR overexpression in cultured cardiac myocytes (3) and transgenic mice (4) . Despite 20-to 200-fold overexpression of ␤AR protein, only 2-fold increases in cAMP production were achieved. Thus, increased ␤AR number does not provide a proportional increase in transmembrane signaling through AC. Similarly, cardiac directed overexpression of G␣s in transgenic mice only modestly increased cardiac adrenergic responsiveness (5) . In these studies a fixed amount of AC may have limited the degree to which increased ␤AR or Gs expression could provoke a meaningful physiological response.
In contrast, manipulation of the amount of AC, independent of changes in receptor number or Gs, may provide a means for the same number of receptors to transduce signals more effectively. Data supporting this previously unexplored concept would provide a rationale for therapeutic strategies designed to amplify transmembrane signaling in the heart in disease states in which reduced adrenergic responsiveness occurs, such as congestive heart failure. In this regard, we and others recently have reported down-regulation of myocardial AC V and AC VI in animal models of heart failure (6, 7). To explore the influence of AC overexpression on transmembrane signaling, we chose to overexpress AC VI in cardiac myocytes because of potential inferences to cardiac pathophysiology. The relationship between AC content and signal transduction was the focus of the current study. We tested two hypotheses: first, that AC content limits adrenergic signal transduction; second, that increased AC, independent of ␤AR number and G-protein content, yields a proportional increase in ␤AR-mediated transmembrane signaling.
METHODS
Plasmid Construction and Recombinant Adenovirus Production. A murine AC VI cDNA (obtained from Dermott Cooper, University of Colorado, Denver) was modified by removing the 3Ј-untranslated region (Fig. 1) . A subfragment containing the 3Ј portion of AC VI with a XhoI site at its 5Ј end was generated by using two PCR primers: AC VI PX, which anneals to AC VI cDNA at bases 2500-2521; and AC VI p3ЈHA, which contains sequences from the 3Ј end of the AC VI coding region and sequences from human influenza hemagglutinin. The PCR product was digested with restriction enzymes XhoI
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© 1998 by The National Academy of Sciences 0027-8424͞98͞951038-6$2.00͞0 PNAS is available online at http:͞͞www.pnas.org. and XbaI, whose sites were incorporated into the primers at the 3Ј end. The 5Ј portion of the AC VI fragment (base pairs Ϫ92 to ϩ2500) was obtained by EcoRI and XhoI digestion of the full-length cDNA and was isolated on an agarose gel. Two AC VI fragments were then subcloned into an EcoRI-XbaIdigested adenovirus vector (pAd5CI) by three-molecule ligation. The pAd5͞CI vector contains a cytomegalovirus immediate-early enhancer͞promoter region (CMV promoter), a chimeric intron, and a multicloning site derived from pCI plasmid DNA (Promega). It also contains a bovine growth hormone poly(A) sequence and partial human adenovirus 5 sequences. The AC VI -containing vector was cotransfected (calcium phosphate) with pJM170 (which contains the adenovirus genome except the E1 region) into a human embryonic kidney cell line (H293). After recombination, plaques were selected and expanded in H293 cells, which have been transformed with adenovirus E1 and therefore provide this viral transcription factor in trans. Expression of AC VI was examined by reverse transcriptase (RT)-PCR and Western blot analysis. Virus was purified by cesium chloride ultracentrifugation and desalted by using Sephadex G-25 equilibrated with PBS. The viral concentration was determined by optical densitometry at 260 nm. Plaque-forming units (pfu) were assayed by plaque titration using H293 cells overlaid with agarose͞Dulbecco's modified Eagle's medium (DMEM).
Identification of AC VI -Expressing Clones. To identify adenovirus clones that expressed AC VI , 16 clones were screened by RT-PCR using a pair of specific primers (AC VI PX and AC VI p3ЈHA) which hybridize to transgene AC VI but not endogenous AC VI in H293 cells. The 512-bp RT-PCR product was confirmed by digestion with the restriction enzyme ApaI to produce 312-bp and 200-bp fragments. Three of 16 clones expressed AC VI mRNA. When tested by transfection of these clones into cardiac myocytes, all three clones showed increased cAMP production in response to stimulation by isoproterenol (clone 1, 22-fold increase; clone 2, 15-fold increase; and clone 3, 12-fold increase) and forskolin (clone 1, 16-fold increase; clone 2, 11-fold increase; and clone 3, 13-fold increase). Clone 1 was selected for subsequent studies.
Cardiac Myocyte Preparation and Gene Transfer. Hearts were removed from 1-to 2-day-old Sprague-Dawley rats, atria and great vessels were discarded, and ventricles were trisected. Myocardium was digested with collagenase II (Worthington) and pancreatin (GIBCO͞BRL Life Technologies), and the myocardial cell suspension was centrifuged through Percoll (Pharmacia Biotechnology) step gradients to separate cardiac myocytes from other cells. Cells were plated (4 ϫ 10 4 cells per cm 2 ) in plates precoated with gelatin, incubated for 24 h, washed with serum-free medium, and maintained in 2% fetal bovine serum for 24 h (8). Gene transfer was performed 3 days after isolation by adding recombinant adenovirus expressing AC VI or lacZ (10 pfu per cell), and incubating for 20 h in DMEM containing 2% fetal bovine serum. Adenovirus was removed and cells were maintained for 24 h prior to study. The extent of gene transfer was evaluated by 5-bromo-4-chloro-3-indolyl ␤-D-galactoside (X-Gal) staining of cells after gene transfer with lacZ. Preliminary studies established that at virus titers of 1, 10, and 100 pfu per cell, 95-100% of cardiac myocytes expressed ␤-galactosidase with no evidence of cytotoxicity (Fig. 2) . The expression of ␤-galactosidase was undetectable in uninfected cells. We selected 10 pfu per cell for our studies.
To determine whether lacZ gene transfer had a deleterious effect on cAMP production, we also studied untransfected cardiac myocytes. These studies showed that untransfected cells were indistinguishable from lacZ-transfected cells in cAMP production in response to 10 M isoproterenol (untransfected, 1.5 Ϯ 0.3 pmol͞g; lacZ, 2.0 Ϯ 0.5 pmol͞g; triplicate samples) or forskolin (untransfected, 0.07 Ϯ 0.01 pmol͞g; lacZ, 0.12 Ϯ 0.04 pmol͞g; triplicate samples). Protein content per well was similar after gene transfer with lacZ and AC VI (lacZ, 32 Ϯ 6 g per well; AC VI , 35 Ϯ 5 g per well; n ϭ 6 each group).
RT-PCR. RT-PCR was used to identify transgene AC VI mRNA. Briefly, 1 g of mRNA was mixed with 100 ng of the primer AC VI 3ЈpHA in 11 l, heated (70°C, 10 min), and quickly chilled on ice. Four microliters of buffer (250 mM Tris⅐HCl, pH 8.3͞375 mM KCl͞15 mM MgCl 2 ), 2 l of 0.1 M DTT, and 1 l of 10 mM dNTP were added, and the reaction mixture was allowed to equilibrate (37°C, 2 min). Finally, 1 l (200 units) of SuperScript II RNase H RT (GIBCO͞BRL Life Technologies) was added; reaction duration was 1 h (37°C). Five microliters of RT product was used as template for PCR using the primers described above. Northern Blot Analysis. Total RNA was isolated from cardiac myocytes 48 h after gene transfer by using Trizon reagent (GIBCO͞BRL Life Technologies). Twenty micrograms of denatured total RNA was electrophoresed in 1ϫ Mops͞EDTA buffer on a 1.0% agarose gel. RNA was transferred to a nylon membrane in 20ϫ SCC and immobilized (80°C, 2 h), and the RNA on the membrane was hybridized with a randomly [ 32 P]dCTP labeled cDNA probe for murine AC VI or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Hybridization was carried out in Hood buffer (50% formamide͞5ϫ SSC͞20 mM sodium phosphate, pH 6.7͞7% SDS͞1% polyethylene glycol 15,000-20,000͞0.5% nonfat dry milk) at 42°C for 16 h. The membrane was washed once with 2ϫ SSC͞0.5% SDS for 30 min (25°C), and two or three times with 0.1ϫ SSC͞0.1% SDS for 30 min each (60-65°C) and exposed to x-ray film.
Western Blot Analysis. Cell lysates were prepared from virus-infected myocytes by using NP-40 lysis buffer [20 mM Hepes, pH 7.0͞120 mM HCl͞1 mM DTT͞5 mM magnesium acetate͞10% (vol͞vol) glycerol͞0.5% Nonidet P-40 containing proteinase inhibitors: 10 g͞ml each of leupeptin, aprotinin, and pepstatin, and 1 mg͞ml Pefabloc (Boehringer Mannheim)] for 10 min on ice. The samples were centrifuged (13,800 ϫ g) for 15 min (4°C). The pellet was resuspended in 1ϫ SDS sample buffer (50 mM Tris⅐HCl, pH 6.8͞100 mM DTT͞2% SDS͞0.1% bromophenol blue͞10% glycerol). Samples were boiled (5 min) and cell lysates were loaded onto an SDS͞7.5% polyacrylamide gel and subjected to electrophoresis. Protein was electrophoretically transferred (1 h, 100 V, 4°C) to nitrocellulose membranes in Tris͞glycine buffer [25 mM Tris⅐HCl, pH 8.3͞150 mM glycine͞10% (vol͞vol) methanol]. The membranes were treated with blocking buffer consisting of 5% nonfat dry milk in Tris͞saline buffer (0.9% NaCl͞10 mM Tris⅐HCl, pH 7.5). For detection of AC VI protein, membranes were incubated with anti-AC V ͞AC VI antibody (Santa Cruz Biotechnology) diluted 1:100 in blocking buffer for 1 h (25°C). For detection of G␣s and G␣i 2 , membranes were incubated with anti-G␣s or anti-G␣i 2 antibodies as previously described (9) . Primary antibodies were detected with goat anti-rabbit IgG conjugated to horseradish peroxidase (GIBCO͞BRL Life Technologies) in blocking buffer. The antigen then was visualized with chemiluminescent substrates A and B (Kirkegaard & Perry Laboratories) and exposed to x-ray film.
[ (1, 2) . As previously described (1, 2), myocytes were infected with adenovirus expressing either AC VI or ␤-galactosidase and cultured for 48 h in 12-well culture plates. Prior to assay, culture medium was aspirated and the cells were washed in reverse buffer (100 mM KCl͞20 mM NaCl͞1 mM NaH 2 PO 4 ͞20 mM Hepes͞1 mM MgSO 4 , pH 7.4). cAMP Measurements. Prior to treatment of cells, growth medium was removed and cells were equilibrated for 30 min (25°C) in serum-free and NaHCO 3 -free DMEM supplemented with 20 mM Hepes, pH 7.2. Subsequently, cells were incubated for 10 min (25°C) in fresh DMEM containing either 10 M isoproterenol or 10 M forskolin in the presence of 0.1 mM ascorbic acid (to prevent oxidization) and 250 M isobutylmethylxanthine, a phosphodiesterase inhibitor. The reaction was terminated by aspiration of medium and addition of 7.5% ice-cold trichloroacetic acid (TCA). TCA extracts were frozen (Ϫ20°C) until assayed. Intracellular cAMP levels were determined by radioimmunoassay (Calbiochem) of TCA extracts after acetylation according to the protocol provided by the manufacturer. The sensitivity of this assay allowed for large dilution of TCA extracts such that extraction of the TCA with ether was unnecessary. Production of cAMP was normalized to the amount of acid-insoluble protein assayed by the Bio-Rad protein assay.
␤-Adrenergic Receptor Binding Studies. ␤ARs were identified in radioligand binding experiments using [ Statistics. Data are reported as mean values Ϯ 1 SD. Data were compared by using Student's t test and, where appropriate, analyses of variance. The null hypothesis was rejected when P Ͻ 0.05.
RESULTS AND DISCUSSION
Adenovirus vectors provide a means to obtain highly efficient gene transfer (10) . In the current study, we obtained Ͼ95% gene transfer in cultured neonatal rat cardiac myocytes (Fig.  2) . We established that transgene DNA and mRNA were present by using PCR, RT-PCR, and Northern blotting (Fig.  3 ). Immunoblotting and [ 3 H]forskolin binding were used to assess transgene protein expression, and both showed evidence for robust expression of transgene AC VI (Figs. 4 and 5 ).
Cardiac myocytes that had received genes on the same day, from the same clone, underwent parallel studies designed to measure [ 3 H]forskolin binding as well as agonist-stimulated cAMP production. The rationale for these studies was to obtain an assessment of the relationship between transgene protein expression and cAMP production. AC VI is present and responsive to Gs-AC interaction (Fig. 5) . AC VI gene transfer was associated with increased cAMP production when stimulated by isoproterenol (lacZ, 26 Ϯ 3 pmol͞g; AC VI , 136 Ϯ 7 pmol͞g; P Ͻ 0.0001) and by forskolin (lacZ, 9 Ϯ 2 pmol͞g; AC VI , 66 Ϯ 8 pmol͞g; P Ͻ 0.0001; n ϭ 3; Fig. 5 ). These data document that cardiac myocytes expressing transgene AC VI have increased adrenergic responsiveness not only to forskolin stimulation, reflecting increased amounts of AC, but also to isoproterenol, indicating that newly synthesized AC is functionally coupled and recruitable through ␤AR stimulation.
[ 3 H]Forskolin binding and stimulation of cAMP formation were increased to a similar degree (6-to 7-fold), indicating that increased AC VI expression resulted in a proportional increase in transmembrane signaling (Fig. 5) . Thus, we have shown that gene transfer of AC VI results in robust transgene expression and proportional increases in protein and enzyme activation. Moreover, in spite of the prominent increase in maximal cAMP synthesis, the apparent EC 50 for isoproterenolstimulated cAMP production was unchanged (lacZ, 16 Ϯ 13 nM; AC VI , 32 Ϯ 19 nM; Fig. 6 ). In a set of experiments where AC VI protein expression was increased 2.1 Ϯ 0.4-fold, there was a 1.9 Ϯ 0.2-fold increase in isoproterenol-stimulated cAMP production (n ϭ 3). These data provide additional confirmation that increased AC expression is associated with a proportional increase in isoproterenol-stimulated cAMP production.
The manipulation of AC expression, with attendant alterations in cAMP production, might be expected to influence the expression of other elements in transmembrane signaling through interaction with cAMP response elements that govern gene transcription (11) . Radioligand binding assays identified similar amounts of specifically bound ICYP per mg of membrane protein in plates of cardiac myocytes infected with adenovirus expressing lacZ (B max , 26 fmol͞mg; K d , 43 pM) or AC VI (B max , 29 fmol͞mg; K d , 78 pM). These data indicate that ␤AR number was unchanged by gene transfer of AC VI . To determine whether increased AC content affected G-protein content, we performed immunoblotting studies with antibodies directed against G␣s and G␣i 2 . These assays identified similar amounts of G␣s and G␣i 2 (Fig. 7) . Thus, the contents of G␣s and G␣i 2 were not changed by gene transfer of AC VI . Quantitatively, ␤AR number and G-protein content were unchanged, and there was a marked increase in G-protein͞AC ratio after gene transfer. Proc. Natl. Acad. Sci. USA 95 (1998) Despite unchanged numbers of cell surface receptors responding to agonist stimulation, and unchanged G-protein content, we were able to amplify cAMP production through ␤AR stimulation manyfold (Figs. 5 and 6). A cell's responsiveness to ␤AR-stimulation, it appears, can be markedly influenced by increasing the expression of the effector (AC) without changing the amount of the receptor. Thus, enhanced adrenergic signaling resulted from AC VI gene transfer and functional coupling of endogenous ␤ARs to AC VI and not from alterations in proximal elements in the pathway.
The molar proportions of the ␤-adrenergic signaling pathway, estimated to be 1:200:3 (␤AR:Gs:AC) in studies conducted on isolated rat cardiac myocytes and other cells (1, 2) suggest that ␤AR number or the amount of AC may limit ␤AR-mediated transmembrane signaling. However, previous studies in the heart have shown that ␤AR overexpression does not yield a proportional increase in agonist-promoted stimulation of cAMP production (3, 4) . Similarly, overexpression of cardiac G␣s has limited effects on adrenergic responsiveness (5) . In contrast, the present study indicates that overexpression of AC VI in cardiac myocytes is associated with a robust amplification of ␤AR-mediated signaling.
The range of relative increases (AC VI vs. lacZ) in adrenergic signaling in the different experiments we conducted deserves comment. Depending on the experiment, our data show 6-to 50-fold amplification of transmembrane signaling. Variations in cell preparation, viral titer, and cAMP assays may contribute to the range in cAMP production that we found. Previous studies examining augmentation of transmembrane adrenergic signaling by altering ␤AR or Gs expression (3) (4) (5) or inhibiting G-protein coupled receptor kinase function (12) typically achieve no more than a 2-fold increase in cAMP production.
Previous studies expressing AC isoforms in cell lines generally have been limited to phenotypic characterization of the transfected isoform (13-15). Krupinski et al. expressed AC VI in H293 cells and showed a response to isoproterenol that was inhibitable by carbachol (14) . No previous study has used AC overexpression in primary cultures of differentiated cells to amplify ␤AR-mediated transmembrane signaling, and none have examined the relationship between the content of AC, ␤AR, G proteins, and cAMP formation. The other major AC isoform in mammalian heart is type V, an isoform that exhibits functional redundancy with type VI (both AC isoforms are unaffected by G␤␥, inhibitable by G␣i, and stimulated by G␣s). We speculate that type V would have similar effects if overexpressed in cardiac myocytes, but these data, to our knowledge, have not been reported in the literature.
In conclusion, we have shown that gene transfer of AC VI into neonatal cardiac myocytes is associated with robust expression of transgene AC VI . Cells that overexpress AC VI respond to agonist stimulation with marked increases in cAMP production proportional to the degree of increased protein expressed. These data indicate that the amount of AC sets a limit on transmembrane ␤-adrenergic signaling, and that using AC VI for gene transfer is a rational approach to obtain proportional increases in ␤-adrenergic signal transduction. Our findings are significant because they establish the importance of AC VI content in modulating transmembrane ␤-adrenergic signaling, and because they suggest a therapeutic target for increasing transmembrane signaling in cardiac conditions associated with desensitization or loss of cAMP formation. We speculate that similar responses are possible in other tissues and organs in which AC plays a physiological role. FIG. 6 . Isoproterenol stimulation. Neonatal rat cardiac myocytes underwent gene transfer using recombinant adenovirus expressing lacZ or ACVI. After gene transfer with ACVI (vs. lacZ), there is an obvious increase in cAMP produced through a wide range of isoproterenol concentrations. The apparent EC50 for isoproterenolstimulated cAMP production was unchanged.
FIG. 7. G-protein Western analysis. Polyclonal antibodies recognizing G␣s (Upper) and G␣i2 (Lower) were used in Western blots of lysates of neonatal rat cardiac myocytes after gene transfer using recombinant adenovirus expressing ACVI (AdV.ACVI) or lacZ (AdV. lacZ). Equal amounts of protein were loaded in each lane. Gene transfer had no effect on immunodetectable G␣s or G␣i2 content. These data indicate that substantial expression of ACVI transgene protein does not alter G␣s or G␣i2 content.
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